BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 29247311)

  • 1. Implementing Group Prenatal Counseling for Expanded Noninvasive Screening Options.
    Gammon BL; Otto L; Wick M; Borowski K; Allyse M
    J Genet Couns; 2018 Aug; 27(4):894-901. PubMed ID: 29247311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre- and post-test genetic counseling for chromosomal and Mendelian disorders.
    Fonda Allen J; Stoll K; Bernhardt BA
    Semin Perinatol; 2016 Feb; 40(1):44-55. PubMed ID: 26718445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Counselors' Perspectives About Cell-Free DNA: Experiences, Challenges, and Expectations for Obstetricians.
    Agatisa PK; Mercer MB; Coleridge M; Farrell RM
    J Genet Couns; 2018 Dec; 27(6):1374-1385. PubMed ID: 29951719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choosing between Higher and Lower Resolution Microarrays: do Pregnant Women Have Sufficient Knowledge to Make Informed Choices Consistent with their Attitude?
    van der Steen SL; Bunnik EM; Polak MG; Diderich KEM; Verhagen-Visser J; Govaerts LCP; Joosten M; Knapen MFCM; Go ATJI; Van Opstal D; Srebniak MI; Galjaard RJH; Tibben A; Riedijk SR
    J Genet Couns; 2018 Feb; 27(1):85-94. PubMed ID: 28674770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing use of existing prenatal genetic tests: Screening and diagnostic testing for aneuploidy.
    Stoll K; Norton ME
    Semin Perinatol; 2018 Aug; 42(5):296-302. PubMed ID: 30209012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women's experiences receiving abnormal prenatal chromosomal microarray testing results.
    Bernhardt BA; Soucier D; Hanson K; Savage MS; Jackson L; Wapner RJ
    Genet Med; 2013 Feb; 15(2):139-45. PubMed ID: 22955112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic counselling, patient education, and informed decision-making in the genomic era.
    Metcalfe SA
    Semin Fetal Neonatal Med; 2018 Apr; 23(2):142-149. PubMed ID: 29233487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin Summary, Number 226.
    Obstet Gynecol; 2020 Oct; 136(4):859-867. PubMed ID: 32976375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What are the required components of pre- and post-test counseling?
    Rink BD; Kuller JA
    Semin Perinatol; 2018 Aug; 42(5):287-289. PubMed ID: 30107889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226.
    ; ;
    Obstet Gynecol; 2020 Oct; 136(4):e48-e69. PubMed ID: 32804883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening.
    Wagner AJ; Mitchell ME; Tomita-Mitchell A
    Clin Perinatol; 2014 Dec; 41(4):957-66. PubMed ID: 25459783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Informed Decision-Making in the Context of Prenatal Chromosomal Microarray.
    Baker J; Shuman C; Chitayat D; Wasim S; Okun N; Keunen J; Hofstedter R; Silver R
    J Genet Couns; 2018 Sep; 27(5):1130-1147. PubMed ID: 29516345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of experiential knowledge on prenatal screening and testing decisions.
    Etchegary H; Potter B; Howley H; Cappelli M; Coyle D; Graham I; Walker M; Wilson B
    Genet Test; 2008 Mar; 12(1):115-24. PubMed ID: 18307384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-Free DNA Screening for Aneuploidy and Microdeletion Syndromes.
    Shaffer BL; Norton ME
    Obstet Gynecol Clin North Am; 2018 Mar; 45(1):13-26. PubMed ID: 29428281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are counsellors' attitudes influencing pregnant women's attitudes and decisions on prenatal screening?
    van den Berg M; Timmermans DR; Kleinveld JH; van Eijk JT; Knol DL; van der Wal G; van Vugt JM
    Prenat Diagn; 2007 Jun; 27(6):518-24. PubMed ID: 17367105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive prenatal testing for fetal aneuploidy and single gene disorders.
    Skrzypek H; Hui L
    Best Pract Res Clin Obstet Gynaecol; 2017 Jul; 42():26-38. PubMed ID: 28342726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Counseling for Patients Considering Screening and Diagnosis for Chromosomal Abnormalities.
    Chard RL; Norton ME
    Clin Lab Med; 2016 Jun; 36(2):227-36. PubMed ID: 27235908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal screening for chromosome abnormalities in a region with no access to termination of pregnancy.
    Paolini CI; Gadow A; Petracchi F; Igarzabal L; Quadrelli R; Gadow EC
    Prenat Diagn; 2009 Jul; 29(7):659-63. PubMed ID: 19360812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing genetic counselor's and patient's perceptions of needs in prenatal chromosomal microarray testing.
    Walser SA; Kellom KS; Palmer SC; Bernhardt BA
    Prenat Diagn; 2015 Sep; 35(9):870-8. PubMed ID: 25995037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes Toward and Uptake of Prenatal Genetic Screening and Testing in Twin Pregnancies.
    Reese KM; Czerwinski J; Darilek S; Johnson A; Jones M; Singletary CN
    J Genet Couns; 2018 Sep; 27(5):1238-1247. PubMed ID: 29525932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.